- Home
- CLBR vs FENC Comparison
CLBR vs FENC Comparison
Compare CLBR & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBR
- FENC
- Stock Information
- Founded
- CLBR 2023
- FENC 1996
- Country
- CLBR United States
- FENC United States
- Employees
- CLBR N/A
- FENC N/A
- Industry
- CLBR
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLBR
- FENC Health Care
- Exchange
- CLBR Nasdaq
- FENC Nasdaq
- Market Cap
- CLBR 222.7M
- FENC 181.7M
- IPO Year
- CLBR 2023
- FENC 2001
- Fundamental
- Price
- CLBR $10.53
- FENC $3.99
- Analyst Decision
- CLBR
- FENC Strong Buy
- Analyst Count
- CLBR 0
- FENC 2
- Target Price
- CLBR N/A
- FENC $14.00
- AVG Volume (30 Days)
- CLBR 190.8K
- FENC 116.0K
- Earning Date
- CLBR 01-01-0001
- FENC 11-07-2024
- Dividend Yield
- CLBR N/A
- FENC N/A
- EPS Growth
- CLBR N/A
- FENC N/A
- EPS
- CLBR N/A
- FENC N/A
- Revenue
- CLBR N/A
- FENC $49,348,000.00
- Revenue This Year
- CLBR N/A
- FENC $116.50
- Revenue Next Year
- CLBR N/A
- FENC $17.49
- P/E Ratio
- CLBR $135.22
- FENC N/A
- Revenue Growth
- CLBR N/A
- FENC 278.09
- 52 Week Low
- CLBR $9.16
- FENC $3.97
- 52 Week High
- CLBR $10.63
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- CLBR 85.18
- FENC 38.47
- Support Level
- CLBR $10.31
- FENC $3.99
- Resistance Level
- CLBR $10.35
- FENC $4.57
- Average True Range (ATR)
- CLBR 0.04
- FENC 0.31
- MACD
- CLBR 0.03
- FENC -0.02
- Stochastic Oscillator
- CLBR 75.00
- FENC 2.33
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.